Oh ... I didn't want to answer you because you claimed you were "too busy at work" ? 4 posts since that claim already this morning may indicate otherwise ... lol
The company has said it will be lodged this quarter (by Sept 30) so no need for concern.... if the "time limit" for resubmission of the BLA for Remestemcel-L to the FDA had expired, then I am guessing Mesoblast wouldn't be making such claims through these 'official' means .... simples !
MSB 2022 - The road to commercialisation, page-1062
-
- There are more pages in this discussion • 467 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
0.010(1.03%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| 96.0¢ | 99.0¢ | 95.5¢ | $5.286M | 5.409M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 91218 | 98.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 63577 | 4 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |